Treatment of drug-induced seizures

British Journal of Clinical Pharmacology

Volumn 81, Issue 3, 2016, Pages 412-419

  Chen, Hsien Yi ^a,b,d   Albertson, Timothy E ^a,c   Olson, Kent R ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

anticonvulsants; poisoning; seizures

Indexed keywords

ADENOSINE DERIVATIVE; CANNABINOID RECEPTOR AGONIST; ETIRACETAM; KETAMINE; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXINE; THIOPENTAL; VALPROIC ACID; ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ASSESSMENT; DRUG INDUCED DISEASE; DRUG INDUCED SEIZURE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; VENTILATION STABILIZATION; CHEMICALLY INDUCED; INTOXICATION; SEIZURES; STATUS EPILEPTICUS;

ANTICONVULSANTS; HUMANS; POISONING; SEIZURES; STATUS EPILEPTICUS;

EID: 84959134172     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12720     Document Type: Article

References (79)

1. Lowenstein DH, Alldredge BK,. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993; 43: 483-8.
2. Pesola GR, Avasarala J,. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. J Emerg Med 2002; 22: 235-9.
3. Alldredge BK, Lowenstein DH, Simon RP,. Seizures associated with recreational drug abuse. Neurology 1989; 39: 1037-9.
4. Delanty N, Vaughan CJ, French JA,. Medical causes of seizures. Lancet 1998; 352: 383-90.
5. Finkelstein Y, Hutson JR, Freedman SB, Wax P, Brent J, Toxicology Investigators Consortium Case Registry. Drug-induced seizures in children and adolescents presenting for emergency care: current and emerging trends. Clin Toxicol 2013; 51: 761-6.
6. Olson KR, Kearney TE, Dyer JE, Benowitz NL, Blanc PD,. Seizures associated with poisoning and drug overdose. Amer J Emerg Med 1993; 11: 565-8.
7. Thundiyil JG, Kearney TE, Olson KR,. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J Med Toxicol 2007; 3: 15-9.
8. Reichert C, Reichert P, Monnet-Tschudi F, Kupferschmidt H, Ceschi A, Rauber-Luthy C,. Seizures after single-agent overdose with pharmaceutical drugs: Analysis of cases reported to a poison center. Clin Toxicol 2014; 52: 629-34.
9. Shadnia S, Brent J, Mousavi-Fatemi K, Hafezi P, Soltaninejad K,. Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients. Basic Clin Pharmacol Toxicol 2012; 111: 133-6.
10. Ryan MN, Isbister GK,. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol 2015; 53: 545-50.
11. A-gated chloride channel blocker. J Toxicol Clin Toxicol 2004; 42: 955-63.
12. Waheed S, Sabeen A, Ullah KN,. New onset refractory status epilepticus as an unusual presentation of a suspected organophosphate poisoning. Case Reports in Emerg Med 2014; 2014: 1-3.
13. Roberts DM, Dissanayake W, Rezvi Sheriff MH, Eddleston M,. Refractory status epilepticus following self-poisoning with the organochlorine pesticide endosulfan. J Clin Neurosci 2004; 11: 760-2.
14. Chau CM, Leung AKH, Tan IKS,. Tetramine poisoning. Hong Kong Med J 2005; 11: 511-4.
15. Moon JM, Chun BJ,. Acute endosulfan poisoning: A retrospective study. Hum Exp Toxicol 2009; 28: 309-16.
16. Legriel S, Azoulay E, Resche-Rigon M, Lemiale V, Mourvillier B, Kouatchet A, Troche G, Wolf M, Galliot R, Dessertaine G, Combaux D, Jacobs F, Beuret P, Megarbane B, Carli P, Lambert Y, Bruneel F, Bedos JP,. Functional outcome after convulsive status epilepticus. Crit Care Med 2010; 38: 2295-303.
17. Thundiyil JG, Rowley F, Papa L, Olson KR, Kearney TE,. Risk factors for complications of drug-induced seizures. J Med Toxicol 2011; 7: 16-23.
18. Buck KJ, Hahner L, Sikela J, Harris RA,. Chronic ethanol treatment alters brain levels of gamma-aminobutyric acid A receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal seizure severity. J Neurochem 1991; 57: 1452-5.
19. Kumar S, Fleming RL, Morrow AL,. Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms. Pharmacol Ther 2004; 101: 211-26.
20. Werner FM, Covenas R,. Review: Classical neurotransmitters and neuropeptides involved in generalized epilepsy in a multi-neurotransmitter system: How to improve the antiepileptic effect? Epilepsy Behav 2015; Mar 26 [Epub ahead of print] [PMID: 25819950].
21. Cerminara C, El-Malhany N, Roberto D, Lo Castro A, Curatolo P,. Seizures induced by desloratadine, a second-generation antihistamine: clinical observations. Neuropediatrics 2013; 44: 222-4.
22. Rejdak K, Nieoczym D, Czuczwar M, Kis J, Wlaz P, Turski WA,. Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine. Pharmacol Rep 2014; 66: 399-403.
23. Avsar E, Empson RM,. Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy. Neuropharmacol 2004; 47: 427-37.
24. Boison D,. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 2005; 11: 25-36.
25. Wygnanski-Jaffe T, Nucci P, Goldchmidt M, Mezer E,. Epilpetic seizures induced by cycloplegic eye drops. Cutan OculToxicol 2014; 33: 103-8.
26. McDonough JH Jr, Shih TM,. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997; 21: 559-79.
27. Curtis DR, Hosli L, Johnston GAR,. A pharmacological study of the depression of spinal neurons by glycine and related amino acids. Exp Brain Res 1968; 6: 1-18.
28. Probst A, Cortes R, Palacois JM,. The distribution of glycine receptors in the human brain. A light microscopic autoradiograhic study using [3H] strychnine. Neuroscience 1986; 17: 11-35.
29. Makarovsky I, Markel G, Hoffman A, Schein O, Brosh-Nissimov T, Tashma Z, Dushnitsky T, Eisenkraft A,. Strychnine-a killer from the past. Isr Med Assoc J 2008; 10: 142-5.
30. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR,. Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992; 359: 832.
31. Patel MM, Tsutaoka BT, Banerji S, Blanc PD, Olson KR,. ED utilization of computed tomography in a poisoned population. Am J Emerg Med 2002; 20: 212-7.
32. Earnest MP, Feldman H, Marx JA, Harris JA, Biletch M, Sullivan LP,. Intracranial lesions shown by CT scans in 259 cases of first alcohol-related seizures. Neurology 1988; 38: 1561-5.
33. Rao RB,. Neurologic Principles. In: Goldfrank's Toxicologic Emergencies, eds, Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR,. New York: McGraw-Hill, 2014.
34. Wallace KL,. Toxin-induced seizures. In: Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient, eds, Brent J, Wallace K, Burkhart K,. Philadelphia, Pennsylvania: Elsevier, 2005.
35. Prasad M, Krishnan PR, Sequeira R, Al-Roomi K,. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2014; 9: CD003723.
36. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB,. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. New Engl J Med 1998; 339: 792-8.
37. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W, NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. New Engl J Med 2012; 366: 591-600.
38. Cawley MJ,. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacother 2001; 21: 1140-4.
39. Starreveld E, Hope E,. Cicutoxin poisoning (water hemlock). Neurology 1975; 25: 730-4.
40. Wood DM, Rajalingam Y, Greene SL, Morgan PE, Gerrie D, Jones AL, Dargan PI,. Status epilepticus following intentional overdose of fluvoxamine: A case report with serum fluvoxamine concentration. Clin Toxicol 2007; 45: 791.
41. Blake KV, Massey KL, Hendeles L, Nickerson D, Neims A,. Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice. Ann Emerg Med 1988; 17: 1024-8.
42. Goldberg MJ, Spector R, Miller G,. Phenobarbital improves survival in theophylline-intoxicated rabbits. J Toxicol Clin Toxicol 1986; 24: 203-11.
43. Bali M, Akabas MH,. Defining the propofol binding site location on the GABA-A receptor. Molecular Pharmacol 2004; 65: 68-76.
44. Curry SC, O'Connor AD, Graeme KA, Mills KC, Sholnik AB,. Neurotransmitters and Neuromodulators. In: Goldfrank's Toxicologic Emergencies, eds, Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR,. New York: McGraw-Hill, 2014.
45. Brown LA, Levin GM,. Role of propofol in refractory status epilepticus. Ann Pharmacother 1998; 32: 1053-9.
46. A receptors. J Medicinal Chem 1998; 41: 1846-54.
47. Orser BA, Bertlik M, Wang LY, MacDonald JF,. Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995; 116: 1761-8.
48. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23.
49. Prabhakar H, Bindra A, Singh GP, Kalaivani M,. Propofol versus thiopental sodium for the treatment of refractory status epilepticus (Review). Evid Based Child Health 2013; 8: 1488-508.
50. Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J,. Propofol treatment of refractory status epilepticus: A study of 31 episodes. Epilepsia 2004; 45: 757-63.
51. Merigian KS, Browning RG, Leeper KV,. Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan). Acad Emerg Med 1995; 2: 128-33.
52. Wang YC, Liu BM, Supernaw RB, Lu YH, Lee PY,. Management of star fruit-induced neurotoxicity and seizures in a patient with chronic renal failure. Pharmacother 2006; 26: 143-6.
53. Sharma AN, Hoffman RJ,. Toxin-related seizures. Emerg Med Clin North Am 2011; 29: 125-39.
54. Seizures. In POISINDEX(R) Managements. Greenwood Village, CO: Thomson Micromedex. Updated periodically. Accessed in 2015.
55. Fudickar A, Bein B,. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol 2009; 75: 339-44.
56. Berger KJ, Guss DA,. Mycotoxins revisitied: Part II. J Emerg Med 2005; 28: 175-83.
57. Lheureux P, Penaloza A, Gris M,. Pyridoxine in clinical toxicology: A review. Eur J Emerg Med 2005; 12: 78-85.
58. Brent J, Vo N, Kulig K, Rumack BH,. Reversal of prolonged isoniazid-induced coma by pyridoxine. Arch Internal Med 1990; 150: 1751-3.
59. Chin L, Sievers ML, Herrier RN, Picchioni AL,. Potentiation of pyridoxine by depressants and anticonvulsants in the treatment of acute isoniazid intoxication in dogs. Toxicol Appl Pharmacol 1981; 58: 504-9.
60. Chin L, Sievers ML, Laird HE, Herrier RN, Picchioni AL,. Evaluation of diazepam and pyridoxine as antidotes to isoniazid intoxication in rats and dogs. Toxicol Appl Pharmacol 1978; 45: 713-22.
61. Tunnicliff G,. Basis of the antiseizure action of phenytoin. Gen Pharmacol 1996; 27: 1091-7.
62. Shah AS, Eddleston M,. Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures? Clin Toxicol 2010; 48: 800-5.
63. Callaham M, Schumaker H, Pentel P,. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning. J Pharmacol Exp Ther 1988; 245: 216-20.
64. Sawaki K, Ohno K, Miyamoto K, Hirai S, Yazaki K, Kawaguchi M,. Effects of anticonvulsants on local anaesthetic-induced neurotoxicity in rats. Pharmacol Toxicol 2000; 86: 59-62.
65. Alldredge BK, Lowenstein DH, Simon RP,. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 1989; 87: 645-8.
66. Chance JF,. Emergency department treatment of alcohol withdrawal seizures with phenytoin. Ann Emerg Med 1991; 20: 520-2.
67. Rathlev NK, D'Onofrio G, Fish SS, Harrison PM, Bernstein E, Hossack RW, Pickens L,. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med 1994; 23: 513-8.
68. Hoffman A, Pinto E, Gilhar D,. Effect of pretreatment with anticonvulsants on theophylline-induced seizures in the rat. J Crit Care 1993; 8: 198-202.
69. Williams AM, Park SH,. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs 2015; 29: 101-11.
70. Zeiler FA,. Early Use of the NMDA receptor antagonist ketamine in refractory and superrefractory status epilepticus. Crit Care Res Pract 2015; Jan 12 2015: 831260. [PMID: 25649724].
71. Shakarjian MP, Ali MS, Veliskova J, Stanton PK, Heck DE, Velisek L,. Combined diazepam and MK-801 therapy provides synergistic protection from tetramethylenedisulfotetramine-induced tonic-clonic seizures and lethality in mice. Neurotoxicology 2015; March 14 [Epub ahead of print] [PMID: 25783504].
72. Kramer AH,. Early ketamine to treat refractory status epilepticus. Neurocrit Care 2012; 16: 299-305.
73. Deshpande LS, DeLorenzo RJ,. Mechanisms of levetiracetam in the control of status epilpeticus and epilepsy. Front Neurol 2014; 5: 1-5.
74. Oliveira AA, Nogueira CRA, Nascimento VS, Aguiar LMV, Freitas RM, Sousa FCF, Viana GSB, Fonteles MMF,. Evaluation of levetiracetam effects on pilocarpine-induced seizures: Cholinergic muscarinic system involvement. Neurosci Lett 2005; 385: 184-8.
75. Myhrer T, Enger S, Jonassen M, Aas P,. Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats. Neurotoxicol 2011; 32: 923-30.
76. Li M, Kang R, Shi J, Liu G, Zhang J,. Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures. PLoS One 2013; 8: e67060.
77. Andres-Mach M, Zolkowska D, Barcicka-Klosowska B, Haratym-Maj A, Florek-Luszczki M, Luszczki JJ,. Effect of ACEA-a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 301-9.
78. Loddenkemper T, Goodkin HP,. Treatment of pediatric status epilepticus. Curr Treat Options Neurol 2011; 13: 560-73.
79. Goralka JM,. Propofol. In: Poisoning & Drug Overdose, 6th edn, ed, Olson KR,. New York: McGraw-Hill, 2012.